Mortuary Training
Mortuary training offers instruction in embalming, mortuary sciences, and funeral directing. Mortuary training courses take approximately one year to complete. An associate degree in funeral service management and specialized technology may require an additional two to four years of formal mortuary training.Some mortuary training programs are available at trade schools and vocational schools, as well as community colleges. Many colleges and universities also offer mortuary training. Topics of study can include human anatomy, physiology, pathology, embalming, environmental health, statistics, restorative art, business administration, accounting, client services, and computers. Additional mortuary training subjects will include social sciences, religious studies, business law, psychology, counseling, oral and written communication, and ethics, giving students a well-rounded education.In addition, mortuary training programs may include lecture courses to develop student awareness and understanding for community and public relations, telephone communications, death and children, and more. Mortuary training programs can include on-site visits to vault and casket companies, crematoriums, monument dealerships, and funeral homes.Some programs in mortuary training will include hands-on training in a licensed funeral home for gaining practical experience. Proper mortuary training programs are accredited and should meet funeral service state licensure requirements.If you would like to learn more about Mortuary Training and Mortuary Schools, you can find more in-depth information and resources on our website.DISCLAIMER: Above is a GENERAL OVERVIEW and may or may not reflect specific practices, courses and/or services associated with ANY ONE particular school(s) that is or is

Child Autism - Is It An Epidemic?
There is a staggering increase in statistics showing child autism as being on the increase. As many as one in a hundred children are now being diagnosed on the autistic spectrum. How many people reading this now know somebody who has an autistic child? In years gone by, I never came into contact with anybody who had a child with an autistic spectrum disorder, but now, this has changed dramatically.So why is there not more in the mainstream press on this subject? There are appears to be very little coverage in the press about what amounts to a major epidemic! We always hear about the latest breakthroughs in cancer research, I am guessing because it helps sell more newspapers.The True Group are an organisation that helps parents of newly diagnosed ASD children. Some of the cases we deal with are quite upsetting, where parents are experiencing all the trauma associated with this terrible affliction on their child. It ranges from depression, anger at the lack of help, despair that their child will never be 'normal', all the way to resignation that their lives will never be the same.I wanted to convey to these parents, that there are many things you can do to help (please visit the website link below for more details). However, in this article, I wanted to discuss whether child autism is in fact an epidemic, or perhaps there is something underlying to this, that would maybe make it more of an illness than a lifelong affliction.For starters, we are in second and third generation of children, whose parents have been vaccinated, have been exposed to a truly awful food chain, pollution, toxicity in things such as tooth amalgams, and water, and the genetic consequences are now being passed on.One of the major things we have discovered on our own personal journey, is that there appears to be a strong correlation between brain activity and the ability to metabolise essen

Business Intelligence Database Systems for Economic Development
Economic development policy is measured by job opportunities, workforce development and business retention and expansion. Business Intelligence Systems are used to enhance economic development, workforce development and business retention and expansion. Business Intelligence Systems for the purpose of Business Retention and Expansion (BRE) are designed to store and report on data used for multi-dimensional, holistic economic development strategies. They help the decision processes by using communication technologies, data, documents, knowledge, and analytical models to identify and solve issues.Business Intelligence Database Systems offer a wide range of solutions for communities, regions and states who want to maximize the return on investment from their retention and expansion programs. For instance, in one state, the current businesses form its existing economic base. These businesses provide the existing jobs and tax base for local and state entities. They also create new jobs, and in fact, studies show that 60-80% of future job growth comes from the expansion of existing businesses.Business Intelligence database software tools make use of community profiling to measure community assets. They also aid professional site location consultants in advising businesses on the most probable business location and/or relocation. Economic development measurements like job creation, economic output and taxable basis are also kept within the business intelligence database system.Questionnaire Development is also a large part of business intelligence database systems. Each community has unique needs and characteristics that should be addressed by its business retention survey. The survey should be customized or tailored to measure the parameters important to the economic development objectives.Example of a Business Intelligence System for Economic Development Companieshis would not be a surprise to the tribal people, who revere Iboga as a god.

Practitioners of West Africa’s Bwiti religion use the iboga plant to induce visions and aid in the hunt. For three hundred years, the tribal people of the rainforest areas have been utilizing this shrub as an integral part of their religious rites. Through its ingestion, they get in touch with their ancestral hierarchy. For example, they may chew on the bark for a day or two and then go into an altered state, where they will dash into the forest and run a mile and a half, then dig under a tree and find a dowry that was put there a hundred and fifty years ago. In the early 1900’s Western scientists discovered, after watching wild boar eat this shrub and go into a frenzy, that iboga is some sort of psychoactive substance. In the 1940’s and 1950’s, pharmaceutical companies began experimenting on some of the alternative uses of the plant, and it was found to be a stimulant. However, in 1962, a man by the name of Howard Lotsof, who was then a heroin addict, took it to get high. After a thirty-six hour trip, he found himself to be free of his addiction, and consequently gave it to six of his friends. Five of them became free of their addictions. Lotsof realized that ibogaine was something beyond just another psychoactive experience.

Over time, the International Coalition for Addict Self-Help ran underground trial testing on ibogaine. Their anecdotal evidence shows roughly seventy-five percent success rates with addiction to heroin, cocaine, amphetamines, alcohol and nicotine.

In 1965, Lotsof formed NDA International and scheduled a use patent on ibogaine for treating drug and alcohol addiction. Scientific study began in the Netherlands in 1991 with more than three dozen addicts as test cases. Since then, the FDA has become very interested in this substance, so much that it has sanctioned the first human studies.

Presently, ibogaine, because of its psychoactive properties, is classified by the FDA as a “Class 1” narcotic (along with heroin and cocaine), and has been outlawed in the U.S. since the 1960’s. Ibogaine, however, is not and never will be a recreational drug. In thirty years of U.S. drug enforcement efforts, only three grams of it has been confiscated “on the street.” An ibogaine treatment, although of substantial benefit to an addict or a person trapped in dysfunctional behavioral patterns, is hard work, and not something people want to repeat. Ibogaine’s true status as a non-addictive substance is demonstrated by the fact that it is legal in every country in the world except the United States and Belgium.

What is an ibogaine treatment like? This depends, to some extent, on the purpose for which the ibogaine is being ingested. The amount of the drug administered varies according to purpose, and the experience is, to some extent, shaped by the intent of the participant. A heroin addict seeking freedom from “the money on her back” will not take the same amount of Ibogaine, or have the same experience as the long time meditator whose goal is to become more connected with the Source, or the therapy patient wanting resolution to a chronic depression or anxiety. Nevertheless, all three will find that

the 1940’s and 1950’s, pharmaceutical companies began experimenting on some of the alternative uses of the plant, and it was found to be a stimulant. However, in 1962, a man by the name of Howard Lotsof, who was then a heroin addict, took it to get high. After a thirty-six hour trip, he found himself to be free of his addiction, and consequently gave it to six of his friends. Five of them became free of their addictions. Lotsof realized that ibogaine was something beyond just another psychoactive experience.

Over time, the International Coalition for Addict Self-Help ran underground trial testing on ibogaine. Their anecdotal evidence shows roughly seventy-five percent success rates with addiction to heroin, cocaine, amphetamines, alcohol and nicotine.

In 1965, Lotsof formed NDA International and scheduled a use patent on ibogaine for treating drug and alcohol addiction. Scientific study began in the Netherlands in 1991 with more than three dozen addicts as test cases. Since then, the FDA has become very interested in this substance, so much that it has sanctioned the first human studies.

Presently, ibogaine, because of its psychoactive properties, is classified by the FDA as a “Class 1” narcotic (along with heroin and cocaine), and has been outlawed in the U.S. since the 1960’s. Ibogaine, however, is not and never will be a recreational drug. In thirty years of U.S. drug enforcement efforts, only three grams of it has been confiscated “on the street.” An ibogaine treatment, although of substantial benefit to an addict or a person trapped in dysfunctional behavioral patterns, is hard work, and not something people want to repeat. Ibogaine’s true status as a non-addictive substance is demonstrated by the fact that it is legal in every country in the world except the United States and Belgium.

What is an ibogaine treatment like? This depends, to some extent, on the purpose for which the ibogaine is being ingested. The amount of the drug administered varies according to purpose, and the experience is, to some extent, shaped by the intent of the participant. A heroin addict seeking freedom from “the money on her back” will not take the same amount of Ibogaine, or have the same experience as the long time meditator whose goal is to become more connected with the Source, or the therapy patient wanting resolution to a chronic depression or anxiety. Nevertheless, all three will find that

and scheduled a use patent on ibogaine for treating drug and alcohol addiction. Scientific study began in the Netherlands in 1991 with more than three dozen addicts as test cases. Since then, the FDA has become very interested in this substance, so much that it has sanctioned the first human studies.

Presently, ibogaine, because of its psychoactive properties, is classified by the FDA as a “Class 1” narcotic (along with heroin and cocaine), and has been outlawed in the U.S. since the 1960’s. Ibogaine, however, is not and never will be a recreational drug. In thirty years of U.S. drug enforcement efforts, only three grams of it has been confiscated “on the street.” An ibogaine treatment, although of substantial benefit to an addict or a person trapped in dysfunctional behavioral patterns, is hard work, and not something people want to repeat. Ibogaine’s true status as a non-addictive substance is demonstrated by the fact that it is legal in every country in the world except the United States and Belgium.

What is an ibogaine treatment like? This depends, to some extent, on the purpose for which the ibogaine is being ingested. The amount of the drug administered varies according to purpose, and the experience is, to some extent, shaped by the intent of the participant. A heroin addict seeking freedom from “the money on her back” will not take the same amount of Ibogaine, or have the same experience as the long time meditator whose goal is to become more connected with the Source, or the therapy patient wanting resolution to a chronic depression or anxiety. Nevertheless, all three will find that

k, and not something people want to repeat. Ibogaine’s true status as a non-addictive substance is demonstrated by the fact that it is legal in every country in the world except the United States and Belgium.

What is an ibogaine treatment like? This depends, to some extent, on the purpose for which the ibogaine is being ingested. The amount of the drug administered varies according to purpose, and the experience is, to some extent, shaped by the intent of the participant. A heroin addict seeking freedom from “the money on her back” will not take the same amount of Ibogaine, or have the same experience as the long time meditator whose goal is to become more connected with the Source, or the therapy patient wanting resolution to a chronic depression or anxiety. Nevertheless, all three will find that their treatment involves physical, psychological, and spiritual dimensions.

All ibogaine treatments have three stages. Stage one involves ingesting the ibogaine, which is given in capsule form. The potency is calibrated according to body weight. In the past, low-does ranges have been used for therapeutic sessions. At a low-dosage level, pictures and insights come slowly enough to be worked with by an attending therapist. A mid-range dose of ibogaine is given to a spiritual seeker wishing to have an initiatory experience. Recent experience suggests, however, that it may be unnecessary to calibrate dosage ranges differently for psychotherapeutic or spiritual purposes. If the person ingesting the ibogaine has experienced severe trauma, it is best to ingest a low-dose and have a therapist on hand, but many people can handle a mid-dose range and can access healing memories on their own.

In many cases, the insights received do not have to be experienced in the traditional Western psychotherapeutic mode. A readied initiate will experience a dissolving of emotional baggage on more abstract levels, which can be shown to be both cumulative and behaviorally altering. A high dose is used to interrupt addictions. It is necessary that the dose be high enough to overwhelm the addict’s drug programmed mind and body. Even at a high dosage range, however, ibogaine does not fragment an addict’s ego, which emerges from the experience intact and cleansed of cravings for the drug or drugs of choice.

The person ingesting the ibogaine may seem to journey backward in time and to re-experience significant life events. Some people undergo a “life review” similar to that described in The Tibetan Book of the Dead, and in modern accounts of near death experiences. If the person is an addict, he or she is sometimes brought to the place where the core issue that helped facilitate the addiction took began. The emotional content of that experience is relived, along with the visual, pictorial gestalt of the experience itself. In most cases, the experience is complete with 3-D effects and the sensation of actually “being there.” Yet, there is also the presence of the witnessing self, who watches and finds understanding. It is this understanding that seems to allow the former addict to begin again, making new, healthy choices.

Miraculously, there are no withdrawal symptoms whatsoever from the former drug, or drugs, of choice. The withdrawal period is interrupted for several reasons. One is that after ingesting the ibogaine, the addicts simply cannot get out of bed to find the fix. Also they are too preoccupied and overwhelmed with that they are experiencing to remember that they need a fix. In addition, medical research conducted at hospitals and universities in this country suggest that ibogaine inhibits the production of dopamine, a neurotransmitter thought to play a central role in addiction. Since many addicts stay addicted simply to avoid the overwhelming pain and stress and withdrawal, absence of withdrawal is a key element of ibogaine’s amazing success in treating addiction.

Stage two of an ibogaine treatment seems to be a somewhat individual experience. Some people sleep for three to twelve hours. Most p